These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 16469865)
1. Novel polymeric prodrug with multivalent components for cancer therapy. Khandare JJ; Chandna P; Wang Y; Pozharov VP; Minko T J Pharmacol Exp Ther; 2006 Jun; 317(3):929-37. PubMed ID: 16469865 [TBL] [Abstract][Full Text] [Related]
2. Camptothecin delivery systems: the utility of amino acid spacers for the conjugation of camptothecin with polyethylene glycol to create prodrugs. Conover CD; Greenwald RB; Pendri A; Shum KL Anticancer Drug Des; 1999 Dec; 14(6):499-506. PubMed ID: 10834271 [TBL] [Abstract][Full Text] [Related]
3. Targeted proapoptotic anticancer drug delivery system. Chandna P; Saad M; Wang Y; Ber E; Khandare J; Vetcher AA; Soldatenkov VA; Minko T Mol Pharm; 2007; 4(5):668-78. PubMed ID: 17685579 [TBL] [Abstract][Full Text] [Related]
4. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy. Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946 [TBL] [Abstract][Full Text] [Related]
5. Assessment of normal and tumor tissue uptake of MAG-CPT, a polymer-bound prodrug of camptothecin, in patients undergoing elective surgery for colorectal carcinoma. Sarapa N; Britto MR; Speed W; Jannuzzo M; Breda M; James CA; Porro M; Rocchetti M; Wanders A; Mahteme H; Nygren P Cancer Chemother Pharmacol; 2003 Nov; 52(5):424-30. PubMed ID: 12904897 [TBL] [Abstract][Full Text] [Related]
6. Albumin-binding prodrugs of camptothecin and doxorubicin with an Ala-Leu-Ala-Leu-linker that are cleaved by cathepsin B: synthesis and antitumor efficacy. Schmid B; Chung DE; Warnecke A; Fichtner I; Kratz F Bioconjug Chem; 2007; 18(3):702-16. PubMed ID: 17378599 [TBL] [Abstract][Full Text] [Related]
7. Reduced toxicity and superior therapeutic activity of a mitomycin C lipid-based prodrug incorporated in pegylated liposomes. Gabizon AA; Tzemach D; Horowitz AT; Shmeeda H; Yeh J; Zalipsky S Clin Cancer Res; 2006 Mar; 12(6):1913-20. PubMed ID: 16551877 [TBL] [Abstract][Full Text] [Related]
8. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties. Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and activity of a folate peptide camptothecin prodrug. Henne WA; Doorneweerd DD; Hilgenbrink AR; Kularatne SA; Low PS Bioorg Med Chem Lett; 2006 Oct; 16(20):5350-5. PubMed ID: 16901694 [TBL] [Abstract][Full Text] [Related]
10. Paclitaxel conjugation with the analog of the gonadotropin-releasing hormone as a targeting moiety. Pribylova M; Dvorakova M; Hanusova V; Nemethova I; Skalova L; Vanek T Int J Pharm; 2011 Aug; 415(1-2):175-80. PubMed ID: 21669266 [TBL] [Abstract][Full Text] [Related]
11. Development of efficient acid cleavable multifunctional prodrugs derived from dendritic polyglycerol with a poly(ethylene glycol) shell. Calderón M; Welker P; Licha K; Fichtner I; Graeser R; Haag R; Kratz F J Control Release; 2011 May; 151(3):295-301. PubMed ID: 21256902 [TBL] [Abstract][Full Text] [Related]
12. Maleimide-oligo(ethylene glycol) derivatives of camptothecin as albumin-binding prodrugs: synthesis and antitumor efficacy. Warnecke A; Kratz F Bioconjug Chem; 2003; 14(2):377-87. PubMed ID: 12643748 [TBL] [Abstract][Full Text] [Related]
13. Poly(ethylene glycol) anticancer drug delivery systems. Greenwald RB P R Health Sci J; 2002 Jun; 21(2):113-21. PubMed ID: 12166021 [No Abstract] [Full Text] [Related]
14. Synthesis and antitumor activity evaluations of albumin-binding prodrugs of CC-1065 analog. Wang Y; Jiang J; Jiang X; Cai S; Han H; Li L; Tian Z; Jiang W; Zhang Z; Xiao Y; Wright SC; Larrick JW Bioorg Med Chem; 2008 Jul; 16(13):6552-9. PubMed ID: 18508273 [TBL] [Abstract][Full Text] [Related]
15. Irinotecan delivery by unimolecular micelles composed of reduction-responsive star-like polymeric prodrug with high drug loading for enhanced cancer therapy. Gao YE; Bai S; Shi X; Hou M; Ma X; Zhang T; Xiao B; Xue P; Kang Y; Xu Z Colloids Surf B Biointerfaces; 2018 Oct; 170():488-496. PubMed ID: 29960949 [TBL] [Abstract][Full Text] [Related]
16. Development of albumin-binding camptothecin prodrugs using a Peptide positional scanning library. Schmid B; Warnecke A; Fichtner I; Jung M; Kratz F Bioconjug Chem; 2007; 18(6):1786-99. PubMed ID: 17915955 [TBL] [Abstract][Full Text] [Related]
18. [Construction and expression of recombinant cecropin B-binding site of luteinizing hormone releasing hormone gene and its anticancer function]. Li XY; Li HL; Zheng GY Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):477-81. PubMed ID: 17961339 [TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of water-soluble glucuronide derivatives of camptothecin for cancer prodrug monotherapy and antibody-directed enzyme prodrug therapy (ADEPT). Leu YL; Roffler SR; Chern JW J Med Chem; 1999 Sep; 42(18):3623-8. PubMed ID: 10479293 [TBL] [Abstract][Full Text] [Related]
20. Ovarian tumor targeting of docetaxel-loaded liposomes mediated by luteinizing hormone-releasing hormone analogues. In vive distribution in nude mice. Qin Y; Song QG; Zhang ZR; Liu J; Fu Y; He Q; Liu J Arzneimittelforschung; 2008; 58(10):529-34. PubMed ID: 19025064 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]